We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares

Delisted

AMYT was delisted on the 11th of April, 2023.

79 hedge funds and large institutions have $720M invested in Amryt Pharma plc American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 18

126% more capital invested

Capital invested by funds: $318M → $720M (+$402M)

57% more funds holding in top 10

Funds holding in top 10: 711 (+4)

39% more funds holding

Funds holding: 5779 (+22)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

100% less call options, than puts

Call options by funds: $20K | Put options by funds: $85.2M

Holders
79
Holders Change
+22
Holders Change %
+38.6%
% of All Funds
1.26%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.18%
New
42
Increased
8
Reduced
10
Closed
18
Calls
$20K
Puts
$85.2M
Net Calls
-$85.2M
Net Calls Change
-$85.2M
Name Holding Trade Value Shares
Change
Change in
Stake
JC
51
JBF Capital
Colorado
$1.09M +$1.06M +75,000 New
VI
52
Vestcor Inc
New Brunswick, Canada
$1.02M +$989K +70,000 New
Arrowstreet Capital
53
Arrowstreet Capital
Massachusetts
$940K +$911K +64,483 New
Osaic Holdings
54
Osaic Holdings
Arizona
$794K +$765K +54,112 +14,165%
Ameriprise
55
Ameriprise
Minnesota
$657K -$2.72M -192,522 -81%
Geode Capital Management
56
Geode Capital Management
Massachusetts
$468K
UBS Group
57
UBS Group
Switzerland
$372K +$304K +21,527 +536%
HSBC Holdings
58
HSBC Holdings
United Kingdom
$366K
HF
59
HRT Financial
New York
$359K +$349K +24,675 New
BHMP
60
Bardin Hill Management Partners
New York
$294K +$284K +20,123 New
E
61
Ergoteles
New York
$291K +$282K +19,936 New
State Street
62
State Street
Massachusetts
$283K -$1.2K -85 -0.4%
VIA
63
Vident Investment Advisory
Georgia
$232K +$225K +15,912 New
OGC
64
One68 Global Capital
New York
$187K +$181K +12,815 New
Simplex Trading
65
Simplex Trading
Illinois
$164K +$159K +11,282 New
TI
66
Trexquant Investment
Connecticut
$152K -$162K -11,475 -52%
SOS
67
Silver Oak Securities
Tennessee
$152K +$147K +10,431 New
JP Morgan Chase
68
JP Morgan Chase
New York
$45K +$43.4K +3,071 +153,550%
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$25K -$17.9K -1,265 -42%
JEST
70
JTC Employer Solutions Trustee
Jersey
$17K
BSC
71
Brown Shipley & Co
United Kingdom
$4.55K +$4.41K +312 New
AA
72
Ancora Advisors
Ohio
$3.24K
FWM
73
Focused Wealth Management
New York
$2.74K
AF
74
Allworth Financial
California
$2.3K +$2.23K +158 New
BTI
75
Blue Trust Inc
Georgia
$1K -$325 -23 -12%

AMYT Hedge Fund Activity: Q1 2023 in Review

79 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q1 2023, worth a combined $720M — up 126% from $318M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMYT positions and 18 closed out — a net gain of 24 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $35.3M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $26.3M sold.

  • 79 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q1 2023, up from 57 in Q4 2022.
  • Funds reported $720M of Amryt Pharma plc American Depositary Shares stock for Q1 2023, up 126% quarter-over-quarter.
  • 42 funds opened new Amryt Pharma plc American Depositary Shares positions in Q1 2023 and 18 closed out, a net change of +24 holders.
  • The largest Amryt Pharma plc American Depositary Shares buyer in Q1 2023 was Pentwater Capital Management, an estimated $35.3M added.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q1 2023 was Rubric Capital Management (New York), an estimated $26.3M sold.

Based on aggregated 13F filings for Q1 2023.